Feb 19, 2026 04:01PM
Jan 16, 2026 01:20PM
Jan 14, 2026 06:48AM
Jan 13, 2026 01:24PM
Jan 13, 2026 12:42PM
Jan 13, 2026 07:27AM
Jan 13, 2026 04:57AM Stifel on Travere Therapeutics (TVTX): 'FSGS Increases Risk of CRL, Though Delay/Approval Still Possible'
Jan 12, 2026 05:00PM
Dec 24, 2025 11:54AM
Dec 23, 2025 05:30PM
Oct 31, 2025 09:04AM
Oct 30, 2025 04:07PM
Sep 26, 2025 07:02AM
Sep 22, 2025 06:45AM H.C. Wainwright Reiterates Buy Rating on Travere Therapeutics (TVTX)
Sep 11, 2025 06:48AM
Sep 10, 2025 11:01AM
Sep 10, 2025 10:30AM
Sep 10, 2025 10:11AM
Sep 10, 2025 09:58AM
Sep 10, 2025 07:01AM
Sep 4, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Travere Therapeutics (TVTX)
Aug 28, 2025 07:33AM
Aug 7, 2025 10:06AM
Aug 6, 2025 04:03PM
Jun 11, 2025 06:19AM
Jun 11, 2025 04:58AM
May 19, 2025 03:38PM
May 16, 2025 09:24AM Stifel Reiterates Hold Rating on Travere Therapeutics (TVTX)
May 16, 2025 06:37AM
May 16, 2025 04:20AM
May 15, 2025 04:22PM
May 1, 2025 04:03PM
Apr 29, 2025 07:07AM
Apr 28, 2025 07:19AM
Apr 23, 2025 09:40AM Cantor Fitzgerald Reiterates Overweight Rating on Travere Therapeutics (TVTX)
Apr 10, 2025 06:28AM
Apr 3, 2025 07:18AM
Apr 2, 2025 07:04AM
Mar 31, 2025 04:31PM
Mar 17, 2025 07:01AM
Feb 24, 2025 04:58AM
Feb 20, 2025 05:19PM Travere Therapeutics (TVTX) Tops Q4 EPS by 17c
Feb 12, 2025 07:10AM
Feb 12, 2025 06:36AM
Jan 22, 2025 03:23PM
Nov 30, 2024 10:00PM
Nov 19, 2024 11:00AM
Nov 8, 2024 06:11AM
Nov 7, 2024 04:02PM Travere Therapeutics (TVTX) Announces Proposed Share Offering
Oct 31, 2024 04:21PM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All